Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,278.00
Bid: 1,278.00
Ask: 1,280.00
Change: 10.00 (0.79%)
Spread: 2.00 (0.156%)
Open: 1,298.00
High: 1,298.00
Low: 1,242.00
Prev. Close: 1,268.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

25 Jul 2019 07:00

RNS Number : 6379G
Victrex PLC
25 July 2019
 
 

 

 

 

25 July 2019

Victrex plc: Interim Management Statement

'Aero, Energy & Medical growth offset by continued Auto & Electronics weakness'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its Interim Management Statement for the third quarter (Q3) covering the period 1 April to 30 June 2019.

Against very strong comparatives in the Industrial division, the Group saw good growth in Aerospace and Energy, whilst in Medical, we continued to see steady growth. In line with macro-indicators and reflecting wider market performance, Automotive, Electronics and Value-Added-Resellers saw some deterioration during Q3.

 

Q3 also saw the final quarterly comparative from the large Consumer Electronics order, with no volumes sold during Q3 2019.

 

Overall, Q3 Group sales volume was down 21% to 912 tonnes (Q3 2018: 1,161 tonnes), with Group revenue down 14% to £72.0m (Q3 2018: £84.0m). Excluding the large Consumer Electronics order, Q3 Group volume was down 18% and Q3 Group revenue was down 12%. Year to date (to the end of Q3) Group sales volume of 2,811 tonnes is 18% down on the prior year (2018 YTD: 3,417 tonnes), with year to date Group revenue (to the end of Q3) of £217.8m down 13% (2018 YTD: £250.6m).

Mega-programme progress

As part of its Polymer & Parts strategy, Victrex continues to focus on delivering further milestones in its growth pipeline and mega-programmes.

 

The Group has now successfully secured the contract from a major US Automotive manufacturer for a supply of PEEK Gears commencing in FY 2020, building on the existing supply to a major European Automotive manufacturer, with over 10 other development programmes also in place.

 

In Aerospace, following completion of the US manufacturing facility which will support our Loaded Brackets and composite parts, the first prototype parts have now been supplied and we also received our first commercial volume order. In Medical, sales of our PEEK-OPTIMA™ HA Enhanced product continue to track above last year, whilst patient recruitment for the PEEK Knee clinical trial has started, with potential for the first implant before the end of our financial year.

 

Financial position and currency

Victrex has seen no material change to its financial position since 31 March 2019. Currency remains broadly neutral for the second half year, with a small tailwind for FY 2020 based on current rates and with nearly 50% of currency hedges in place.

 

Outlook

With continued weakness in Automotive and Electronics, we remain cautious on these markets, in line with the latest macro-indicators. Whilst we do not expect a recovery in these markets during the final quarter, our own sales and innovation activity, together with slightly better comparatives, offers the opportunity to deliver a more stable performance for the remainder of our financial year.

 

Victrex remains in a good position for the medium to longer term. Through our Polymer & Parts strategy we have the opportunity to drive growth in our core business, further increase our differentiation through our strong pipeline of new products and deliver attractive returns to shareholders. 

 

Analyst & investor conference call

A conference call for analysts & investors will be held today, Thursday 25 July, at 08.00am BST.

Dial in details: +44 (0) 3333 000804 PIN: 82241272#

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Communications +44 (0) 7809 595831

Richard Armitage, Chief Financial Officer +44 (0) 1253 897700

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy (including manufacturing & engineering), electronics and medical. Every day, millions of people use products and applications, which contain our materials - from smart phones, aeroplanes and cars to oil and gas operations and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTRIMRTMBITBPL
Date   Source Headline
31st Aug 20173:31 pmRNSTotal Voting Rights
17th Aug 201711:39 amRNSDirector/PDMR Shareholding
31st Jul 201710:36 amRNSTotal Voting Rights
25th Jul 20177:00 amRNSTrading Statement
18th Jul 20172:10 pmRNSDirector/PDMR Shareholding
30th Jun 20172:09 pmRNSTotal Voting Rights
19th Jun 20174:18 pmRNSDirector/PDMR Shareholding
1st Jun 20179:51 amRNSBlock listing Interim Review
31st May 20179:22 amRNSTotal Voting Rights
31st May 20179:05 amRNSHolding(s) in Company
19th May 20179:39 amRNSAdditional Listing
18th May 201710:23 amRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
28th Apr 20172:39 pmRNSTotal Voting Rights
19th Apr 20172:17 pmRNSDirector/PDMR Shareholding
19th Apr 20177:57 amRNSDirectorate Change
6th Apr 20177:00 amRNSAcquisition
31st Mar 201710:32 amRNSTotal Voting Rights
28th Mar 20177:00 amRNSCapital Markets Day
24th Mar 20172:44 pmRNSHolding(s) in Company
17th Mar 20172:12 pmRNSDirector/PDMR Shareholding
17th Mar 20179:34 amRNSHolding(s) in Company
14th Mar 201710:56 amRNSHolding(s) in Company
9th Mar 20174:33 pmRNSHolding(s) in Company
28th Feb 201710:49 amRNSTotal Voting Rights
17th Feb 201711:30 amRNSDirector/PDMR Shareholding
8th Feb 20171:59 pmRNSResult of AGM
8th Feb 20179:00 amRNSAudit Tender Notification
8th Feb 20177:00 amRNSAGM Statement
31st Jan 20173:54 pmRNSTotal Voting Rights
17th Jan 20172:52 pmRNSDirector/PDMR Shareholding
5th Jan 201711:31 amRNSAnnual Financial Report
30th Dec 201611:37 amRNSHolding(s) in Company
30th Dec 201610:00 amRNSTotal Voting Rights
21st Dec 20169:14 amRNSDirector Declaration
19th Dec 201612:54 pmRNSDirector/PDMR Shareholding
15th Dec 20169:02 amRNSDirector Declaration
8th Dec 20163:41 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSFinal Results
1st Dec 201611:53 amRNSBlock listing Interim Review
30th Nov 20161:30 pmRNSTotal Voting Rights
17th Nov 20162:19 pmRNSDirector/PDMR Shareholding
10th Nov 201611:11 amRNSAdditional Listing
31st Oct 20162:39 pmRNSTotal Voting Rights
18th Oct 20162:10 pmRNSDirector/PDMR Shareholding
11th Oct 20167:00 amRNSTrading Statement
30th Sep 20161:11 pmRNSTotal Voting Rights
19th Sep 20164:28 pmRNSDirector/PDMR Shareholding
19th Sep 20163:18 pmRNSHolding(s) in Company
31st Aug 20169:28 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.